Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
EGFR | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 9.88E3 | Evidence | |||||
EGFR | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 8.52E3 | Evidence | |||||
EGFR | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 4.98E3 | Evidence | |||||
EGFR | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 200.0 | Evidence | |||||
EGFR | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 200.0 | Evidence | |||||
EGFR | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 200.0 | Evidence | |||||
EGFR | NCK2 | NCK2: Cytoplasmic protein NCK2 | 200.0 | Evidence | |||||
EGFR | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence | |||||
EGFR | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 200.0 | Evidence | |||||
EGFR | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 125.0 | Evidence | |||||
EGFR | CRKL | CRKL: Crk-like protein | 121.0 | Evidence | |||||
EGFR | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 121.0 | Evidence | |||||
EGFR | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 121.0 | Evidence | |||||
EGFR | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 121.0 | Evidence | |||||
EGFR | STAT3 | 117.0 | Evidence | ||||||
EGFR | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 117.0 | Evidence | |||||
EGFR | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 117.0 | Evidence | |||||
EGFR | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence | |||||
EGFR | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 110.0 | Evidence | |||||
EGFR | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 89.20 | Evidence | |||||
EGFR | LYN | LYN: Tyrosine-protein kinase Lyn | 89.20 | Evidence | |||||
EGFR | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 89.20 | Evidence | |||||
EGFR | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 89.20 | Evidence | |||||
EGFR | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 89.20 | Evidence | |||||
EGFR | BMX | N/A | 89.20 | Evidence | |||||
EGFR | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 79.90 | Evidence | |||||
EGFR | HCK | N/A | 79.90 | Evidence | |||||
EGFR | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 79.90 | Evidence | |||||
EGFR | SYK | SYK: Tyrosine-protein kinase SYK | 79.90 | Evidence | |||||
EGFR | JAK1 | 79.90 | Evidence | ||||||
EGFR | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 67.1 | Evidence | |||||
EGFR | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 64.40 | Evidence | |||||
EGFR | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 44.00 | Evidence | |||||
EGFR | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 40.60 | Evidence | |||||
EGFR | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | INSR | INSR: Insulin receptor precursor | 33.90 | Evidence | |||||
EGFR | KIT | KIT: Mast/stem cell growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 30.10 | Evidence | |||||
EGFR | GRAP | GRAP: GRB2-related adapter protein | 23.20 | Evidence | |||||
EGFR | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 20.50 | Evidence | |||||
EGFR | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 20.50 | Evidence | |||||
EGFR | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 20.50 | Evidence | |||||
EGFR | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor | 19.70 | Evidence | |||||
EGFR | EGF | EGF: Pro-epidermal growth factor precursor | 19.70 | Evidence | |||||
EGFR | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 19.70 | Evidence | |||||
EGFR | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 19.70 | Evidence | |||||
EGFR | ICAM3 | ICAM3: Intercellular adhesion molecule 3 precursor | 19.70 | Evidence | |||||
EGFR | BTC | BTC: Probetacellulin precursor [Contains: Betacellulin | 19.70 | Evidence | |||||
EGFR | TGFA | TGFA: Protransforming growth factor alpha precursor [Contains: Transforming grow | 19.70 | Evidence | |||||
EGFR | ITGB4 | N/A | 19.70 | Evidence | |||||
EGFR | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 17.60 | Evidence | |||||
EGFR | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 17.60 | Evidence | |||||
EGFR | JAG2 | JAG2: Jagged-2 precursor | 17.60 | Evidence | |||||
EGFR | GHR | GHR: Growth hormone receptor precursor | 15.00 | Evidence | |||||
EGFR | EPOR | EPOR: Erythropoietin receptor precursor | 15.00 | Evidence | |||||
EGFR | IQGAP1 | IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 | 13.50 | Evidence | |||||
EGFR | STAM2 | STAM2: Signal transducing adapter molecule 2 | 13.50 | Evidence | |||||
EGFR | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 13.50 | Evidence | |||||
EGFR | VASP | VASP: Vasodilator-stimulated phosphoprotein | 13.00 | Evidence | |||||
EGFR | MT2A | MT2A, CES1, MT2: Metallothionein-2 | 13.00 | Evidence | |||||
EGFR | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 13.00 | Evidence | |||||
EGFR | NF2 | NF2, SCH: Merlin | 13.00 | Evidence | |||||
EGFR | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 11.60 | Evidence | |||||
EGFR | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 11.60 | Evidence | |||||
EGFR | DOK1 | DOK1: Docking protein 1 | 11.60 | Evidence | |||||
EGFR | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 11.60 | Evidence | |||||
EGFR | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 11.60 | Evidence | |||||
EGFR | CAPN2 | CAPN2, CANPL2: Calpain-2 catalytic subunit precursor | 11.60 | Evidence | |||||
EGFR | COL5A1 | N/A | 11.40 | Evidence | |||||
EGFR | SHC2 | N/A | 10.70 | Evidence | |||||
EGFR | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 10.30 | Evidence | |||||
EGFR | ATP2A3 | ATP2A3: Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 9.96 | Evidence | |||||
EGFR | EFNA1 | EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor | 9.06 | Evidence | |||||
EGFR | CD82 | CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen | 8.92 | Evidence | |||||
EGFR | GNAT1 | GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit | 8.92 | Evidence | |||||
EGFR | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 8.92 | Evidence | |||||
EGFR | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 8.89 | Evidence | |||||
EGFR | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 8.89 | Evidence | |||||
EGFR | SOS1 | SOS1: Son of sevenless homolog 1 | 8.55 | Evidence | |||||
EGFR | MET | MET: Hepatocyte growth factor receptor precursor | 7.59 | Evidence | |||||
EGFR | ANXA2 | ANXA2, ANX2, ANX2L4, CAL1H, LPC2D: Annexin A2 | 6.24 | Evidence | |||||
EGFR | YLPM1 | N/A | 6.14 | Evidence | |||||
EGFR | CSH2 | GH1: Somatotropin precursor | 5.87 | Evidence | |||||
EGFR | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 5.87 | Evidence | |||||
EGFR | GRIA3 | GRIA3, GLUR3, GLURC: Glutamate receptor 3 precursor | 5.59 | Evidence | |||||
EGFR | GRIN1 | GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor | 5.59 | Evidence | |||||
EGFR | CAV1 | CAV1, CAV: Caveolin-1 | 5.50 | Evidence | |||||
EGFR | DPP8 | DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 | 5.26 | Evidence | |||||
EGFR | THOP1 | THOP1: Thimet oligopeptidase | 5.26 | Evidence | |||||
EGFR | HSP90AA1 | Hsp89-alpha-delta-N | 5.26 | Evidence | |||||
EGFR | KLK6 | KLK6, PRSS18, PRSS9: Kallikrein-6 precursor | 5.26 | Evidence | |||||
EGFR | WASPIP | N/A | 5.26 | Evidence | |||||
EGFR | HSP90B1 | HSP90B1, TRA1: Endoplasmin precursor | 5.26 | Evidence | |||||
EGFR | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 5.26 | Evidence | |||||
EGFR | ALK | ALK: ALK tyrosine kinase receptor precursor | 5.26 | Evidence | |||||
EGFR | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 4.78 | Evidence | |||||
EGFR | SERPINA3 | N/A | 4.78 | Evidence | |||||
EGFR | SERPINA6 | SERPINA6, CBG: Corticosteroid-binding globulin precursor | 4.78 | Evidence | |||||
EGFR | ILK | ILK, ILK1, ILK2: Integrin-linked protein kinase | 4.28 | Evidence | |||||
EGFR | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 4.03 | Evidence | |||||
EGFR | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 4.01 | Evidence | |||||
EGFR | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 4.01 | Evidence | |||||
EGFR | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 4.01 | Evidence | |||||
EGFR | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 3.61 | Evidence | |||||
EGFR | ASGR2 | ASGR2: Asialoglycoprotein receptor 2 | 3.34 | Evidence | |||||
EGFR | TRPV2 | TRPV2: Uncharacterized protein TRPV2 | 3.18 | Evidence | |||||
EGFR | SIGLEC6 | N/A | 3.18 | Evidence | |||||
EGFR | IL31RA | IL31RA, CRL3, UNQ6368/PRO21073/PRO21384, GPL: Interleukin-31 receptor A precurso | 3.18 | Evidence | |||||
EGFR | CD37 | CD37, TSPAN26: Leukocyte antigen CD37 | 3.05 | Evidence | |||||
EGFR | TSPAN9 | TSPAN9, NET5: Tetraspanin-9 | 3.05 | Evidence | |||||
EGFR | DLG1 | N/A | 2.99 | Evidence | |||||
EGFR | STK39 | STK39, SPAK: STE20/SPS1-related proline-alanine-rich protein kinase | 2.99 | Evidence | |||||
EGFR | CELSR1 | CELSR1, CDHF9, FMI2: Cadherin EGF LAG seven-pass G-type receptor 1 precursor | 2.85 | Evidence | |||||
EGFR | EFNA2 | EFNA2, EPLG6, LERK6: Ephrin-A2 precursor | 2.60 | Evidence |